193 related articles for article (PubMed ID: 36376971)
1. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.
Sharma M; Dey CS
Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971
[TBL] [Abstract][Full Text] [Related]
2. Role of Akt isoforms in neuronal insulin signaling and resistance.
Sharma M; Dey CS
Cell Mol Life Sci; 2021 Dec; 78(23):7873-7898. PubMed ID: 34724097
[TBL] [Abstract][Full Text] [Related]
3. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
Brognard J; Sierecki E; Gao T; Newton AC
Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
[TBL] [Abstract][Full Text] [Related]
4. PP1γ regulates neuronal insulin signaling and aggravates insulin resistance leading to AD-like phenotypes.
Yadav Y; Sharma M; Dey CS
Cell Commun Signal; 2023 Apr; 21(1):82. PubMed ID: 37085815
[TBL] [Abstract][Full Text] [Related]
5. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of PHLPP phosphatases in the nervous system.
Mallick A; Sharma M; Dey CS
Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
[TBL] [Abstract][Full Text] [Related]
8. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
9. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
[TBL] [Abstract][Full Text] [Related]
10. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
Rajala RV; Kanan Y; Anderson RE
Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
[TBL] [Abstract][Full Text] [Related]
11. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.
Liu J; Stevens PD; Li X; Schmidt MD; Gao T
Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499
[TBL] [Abstract][Full Text] [Related]
12. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
13. AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance.
Sharma M; Dey CS
Rev Endocr Metab Disord; 2021 Dec; 22(4):973-986. PubMed ID: 33928491
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.
Cozzone D; Fröjdö S; Disse E; Debard C; Laville M; Pirola L; Vidal H
Diabetologia; 2008 Mar; 51(3):512-21. PubMed ID: 18204829
[TBL] [Abstract][Full Text] [Related]
15. PHLPPs: Emerging players in metabolic disorders.
Balamurugan K; Chandra K; Sai Latha S; Swathi M; Joshi MB; Misra P; Parsa KVL
Drug Discov Today; 2022 Oct; 27(10):103317. PubMed ID: 35835313
[TBL] [Abstract][Full Text] [Related]
16. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis.
Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T
Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341
[TBL] [Abstract][Full Text] [Related]
17. Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL.
Kanan Y; Matsumoto H; Song H; Sokolov M; Anderson RE; Rajala RV
J Neurochem; 2010 Apr; 113(2):477-88. PubMed ID: 20089132
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
19. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
20. The phosphatase PHLPP controls the cellular levels of protein kinase C.
Gao T; Brognard J; Newton AC
J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
